Kerecis Expands Silicone Fish-Skin Line with SurgiClose®
Kerecis, a leader in the use of sustainably sourced fish skin and fatty acids for cellular therapy, tissue regeneration, and protection, has announced the launch of SurgiClose® Silicone. This innovative product combines fish-skin grafts with a silicone backing, providing an efficient solution for treating surgical and trauma wounds.
SurgiClose® Silicone is part of the SurgiClose® product family, which features intact fish-skin grafts designed for managing trauma and surgical wounds in the operating room. The new product is available in two variations: SurgiClose® Silicone Adhesive, which has borders that overlap the fish-skin underneath, and SurgiClose® Silicone Standard, with non-overlapping borders. Both versions offer enhanced flexibility and efficiency in wound care, enabling healthcare professionals to choose the best option for specific wound types.
Fertram Sigurjonsson, the Founder and CEO of Kerecis, explained that applying Kerecis fish-skin to surgical or trauma wounds typically requires multiple supporting products, such as sutures, staples, surgical tapes, contact layers, and other dressings. The introduction of SurgiClose® Silicone combines fish-skin with a silicone contact layer, eliminating the need for one of these supporting products. This simplifies the workflow in the surgical theater, reduces the number of materials required, and lowers costs, making it a more efficient solution for both healthcare providers and patients.
Kerecis is at the forefront of using fish-skin in medical treatments. The company’s products harness the natural properties of fish skin and fatty acids to support the body’s healing and regenerative processes. When grafted onto damaged human tissue or implanted, Kerecis’ fish-skin material acts as a scaffold that encourages tissue regeneration. The material is processed to retain the skin’s original three-dimensional structure, preserving its strength and complexity. This gentle processing helps Kerecis’ fish-skin products maintain critical molecules, such as fatty acids, that aid in tissue repair.
A major advantage of Kerecis’ fish-skin products is the lack of disease-transfer risk between cold-water fish and humans. This makes Kerecis products safer than other biologic materials that may carry a higher risk of disease transmission. Clinical studies have demonstrated that Kerecis’ fish-skin-based products are more effective in promoting wound healing than competitor products, leading to faster recovery times for patients.
Kerecis is the only global manufacturer of medical devices containing intact fish skin and is rapidly growing in the U.S. biologics skin market. The company’s product range includes SurgiBind®/SuriClose®, GraftGuide®, MariGen®, and Shield™, which are used for various medical applications. These products are renowned for accelerating healing, reducing the need for further surgeries, and improving patient outcomes in wound care settings.
Sustainability is at the core of Kerecis’ operations. The company uses sustainably sourced Icelandic fish, processed with renewable energy. This commitment to sustainability aligns with the United Nations Sustainable Development Goals (SDGs), helping to reduce its environmental footprint while providing high-quality healthcare solutions. It’ sustainability efforts extend across its manufacturing processes and product offerings, ensuring minimal environmental impact.
It is also part of Coloplast, a global leader in intimate healthcare products. This partnership allows Kerecis to leverage Coloplast’s vast healthcare expertise while continuing to innovate and expand its product portfolio. Through its collaboration with Coloplast, Kerecis has solidified its position as a global leader in biologic skin products, ensuring the continued development of advanced wound care solutions.
In conclusion, Kerecis’ launch of SurgiClose® Silicone represents a significant advancement in the treatment of surgical and trauma wounds. By combining fish-skin grafts with a silicone backing, this new product simplifies the wound care process, reduces costs, and improves patient outcomes. With its unwavering commitment to sustainability, innovation, and clinical excellence, This company is poised to continue leading the way in the biologic skin market, helping to transform wound care for years to come.
Please find the related post
